Improving Glare and Visual Comfort for Patients With Visual Impairment
NCT ID: NCT05829135
Last Updated: 2025-06-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2023-05-01
2025-06-16
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pilot Clinical Evaluation of Approved Contact Lenses
NCT02540122
Visual Outcomes and Contrast Sensitivity After Myopic LASIK
NCT01746589
The Effects of Contact Lenses With UV/HEV-Filter on Visual Function
NCT05601544
Ocular Adaptation and Visual Performance for Accommodative Contact Lens
NCT02923232
Evaluating and Improving Functional Driving Vision of Patients With Astigmatism
NCT02624791
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Purpose of this study is to assess whether individuals with visual impairment may benefit from these lenses to minimize glare, light sensitivity symptoms and improve the overall visual comfort.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Treatment group
All participants will be fit with Acuvue Oasys with Transitions.
Acuvue Oasys with Transitions
soft contact lenses with darkening technology
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Acuvue Oasys with Transitions
soft contact lenses with darkening technology
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Able to speak and read English
* Experience glare and light sensitivity that impacts patient's daily living activities
* Have confirmed diagnosis of ocular condition including but not limited to Stargardt's, Cone dystrophy, Cone-rod dystrophy, Albinism, Retinitis Pigmentosa and Achromatopsia.
* Willing and able to wear the contact lenses as instructed
Exclusion Criteria
* Have current/recent ocular infection, inflammation, surgery in the past 3 months that contraindicates contact lens wear
18 Years
64 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
American Academy of Optometry
OTHER
Nova Southeastern University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
So Yeon Lee
Assistant professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
So Yeon Lee, OD
Role: STUDY_CHAIR
Nova Southeastern University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Nova Southeastern University
Davie, Florida, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020-128
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.